Home Table of Contents

§ 21-2C-07. Study of aspects of pharmaceutical distribution and payment; report

West's Annotated Code of MarylandHealth--GeneralEffective: June 1, 2020

West's Annotated Code of Maryland
Health--General
Title 21. Food, Drugs, and Cosmetics (Refs & Annos)
Subtitle 2c. Prescription Drug Affordability Board (Refs & Annos)
Effective: June 1, 2020
MD Code, Health - General, § 21-2C-07
§ 21-2C-07. Study of aspects of pharmaceutical distribution and payment; report
Currentness
On or before December 31, 2021, the Board, in consultation with the Stakeholder Council, shall:
(1) Study:
(i) The entire pharmaceutical distribution and payment system in the State; and
(ii) Policy options being used in other states and countries to lower the list price of pharmaceuticals, including:
1. Setting upper payment limits;
2. Using a reverse auction marketplace; and
3. Implementing a bulk purchasing process; and
(2) Report its findings and recommendations, including findings for each option studied under item (1)(ii) of this section and any legislation required to implement the recommendations, to the Senate Finance Committee and the House Health and Government Operations Committee in accordance with § 2-1257 of the State Government Article.

Credits

Added by Acts 2019, c. 692, § 1, eff. July 1, 2019. Amended by Acts 2019, c. 510, § 4; Acts 2019, c. 511, § 4. Amended by Acts 2020, c. 425, § 1, eff. June 1, 2020.
MD Code, Health - General, § 21-2C-07, MD HEALTH GEN § 21-2C-07
Current through legislation effective through April 9, 2023, from the 2024 Regular Session of the General Assembly. Some statute sections may be more current, see credits for details.
End of Document